Literature DB >> 16236819

Acute hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells.

Oleksandr Platoshyn1, Elena E Brevnova, Elyssa D Burg, Ying Yu, Carmelle V Remillard, Jason X-J Yuan.   

Abstract

Acute hypoxia causes pulmonary vasoconstriction in part by inhibiting voltage-gated K(+) (Kv) channel activity in pulmonary artery smooth muscle cells (PASMC). The hypoxia-mediated decrease in Kv currents [I(K(V))] is selective to PASMC; hypoxia has little effect on I(K(V)) in mesenteric artery smooth muscle cells (MASMC). Functional Kv channels are homo- and/or heterotetramers of pore-forming alpha-subunits and regulatory beta-subunits. KCNA5 is a Kv channel alpha-subunit that forms functional Kv channels in PASMC and regulates resting membrane potential. We have shown that acute hypoxia selectively inhibits I(K(V)) through KCNA5 channels in PASMC. Overexpression of the human KCNA5 gene increased I(K(V)) and caused membrane hyperpolarization in HEK-293, COS-7, and rat MASMC and PASMC. Acute hypoxia did not affect I(K(V)) in KCNA5-transfected HEK-293 and COS-7 cells. However, overexpression of KCNA5 in PASMC conferred its sensitivity to hypoxia. Reduction of Po(2) from 145 to 35 mmHg reduced I(K(V)) by approximately 40% in rat PASMC transfected with human KCNA5 but had no effect on I(K(V)) in KCNA5-transfected rat MASMC (or HEK and COS cells). These results indicate that KCNA5 is an important Kv channel that regulates resting membrane potential and that acute hypoxia selectively reduces KCNA5 channel activity in PASMC relative to MASMC and other cell types. Because Kv channels (including KCNA5) are ubiquitously expressed in PASMC and MASMC, the observation from this study indicates that a hypoxia-sensitive mechanism essential for inhibiting KCNA5 channel activity is exclusively present in PASMC. The divergent effect of hypoxia on I(K(V)) in PASMC and MASMC also may be due to different expression levels of KCNA5 channels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236819      PMCID: PMC1363730          DOI: 10.1152/ajpcell.00028.2005

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  57 in total

1.  Pulmonary artery smooth muscle cell [Ca2+]i and contraction: responses to diphenyleneiodonium and hypoxia.

Authors:  F Zhang; R C Carson; H Zhang; G Gibson; H M Thomas
Journal:  Am J Physiol       Date:  1997-09

2.  Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells.

Authors:  J Wang; M Juhaszova; L J Rubin; X J Yuan
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

3.  O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase.

Authors:  S L Archer; H L Reeve; E Michelakis; L Puttagunta; R Waite; D P Nelson; M C Dinauer; E K Weir
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Oxygen sensitivity of mitochondrial metabolic state in isolated skeletal and cardiac myocytes.

Authors:  K N Richmond; S Burnite; R M Lynch
Journal:  Am J Physiol       Date:  1997-11

5.  Regulation of the resting potential of rabbit pulmonary artery myocytes by a low threshold, O2-sensing potassium current.

Authors:  O N Osipenko; A M Evans; A M Gurney
Journal:  Br J Pharmacol       Date:  1997-04       Impact factor: 8.739

6.  Identification, cloning and expression of rabbit vascular smooth muscle Kv1.5 and comparison with native delayed rectifier K+ current.

Authors:  O Clément-Chomienne; K Ishii; M P Walsh; W C Cole
Journal:  J Physiol       Date:  1999-03-15       Impact factor: 5.182

7.  Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes.

Authors:  A J Patel; M Lazdunski; E Honoré
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

8.  Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes.

Authors:  S L Archer; E Souil; A T Dinh-Xuan; B Schremmer; J C Mercier; A El Yaagoubi; L Nguyen-Huu; H L Reeve; V Hampl
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.

Authors:  N S Chandel; E Maltepe; E Goldwasser; C E Mathieu; M C Simon; P T Schumacker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

10.  Kvbeta1.2 subunit coexpression in HEK293 cells confers O2 sensitivity to kv4.2 but not to Shaker channels.

Authors:  M T Pérez-García; J R López-López; C González
Journal:  J Gen Physiol       Date:  1999-06       Impact factor: 4.086

View more
  29 in total

1.  Hypoxic pulmonary vasoconstriction, carotid body function and erythropoietin production in adult rats perinatally exposed to hyperoxia.

Authors:  Jesus Prieto-Lloret; Maria Ramirez; Elena Olea; Javier Moral-Sanz; Angel Cogolludo; Javier Castañeda; Sara Yubero; Teresa Agapito; Angela Gomez-Niño; Asuncion Rocher; Ricardo Rigual; Ana Obeso; Francisco Perez-Vizcaino; Constancio González
Journal:  J Physiol       Date:  2015-05-15       Impact factor: 5.182

2.  Tetramerization domain mutations in KCNA5 affect channel kinetics and cause abnormal trafficking patterns.

Authors:  Elyssa D Burg; Oleksandr Platoshyn; Igor F Tsigelny; Beatriz Lozano-Ruiz; Brinda K Rana; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

Review 3.  Two-pore potassium channels in the cardiovascular system.

Authors:  Alison Gurney; Boris Manoury
Journal:  Eur Biophys J       Date:  2008-05-01       Impact factor: 1.733

Review 4.  Regulation of ion channels by pyridine nucleotides.

Authors:  Peter J Kilfoil; Srinivas M Tipparaju; Oleg A Barski; Aruni Bhatnagar
Journal:  Circ Res       Date:  2013-02-15       Impact factor: 17.367

5.  BK channels in rat and human pulmonary smooth muscle cells are BKα-β1 functional complexes lacking the oxygen-sensitive stress axis regulated exon insert.

Authors:  Neil D Detweiler; Li Song; Samantha J McClenahan; Rachel J Versluis; Sujay V Kharade; Richard C Kurten; Sung W Rhee; Nancy J Rusch
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

6.  The augmenter of liver regeneration protects the kidneys after orthotopic liver transplantation possibly by upregulating HIF-1α and O2-sensitive K+ channels.

Authors:  Yao Chen; Fang Luo; Shiqiao Luo; Zhongjun Wu; Jian Zhou
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

7.  Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5.

Authors:  Laurie K Svoboda; Khalilah G Reddie; Lian Zhang; Eileen D Vesely; Elizabeth S Williams; Sarah M Schumacher; Ryan P O'Connell; Robin Shaw; Sharlene M Day; Justus M Anumonwo; Kate S Carroll; Jeffrey R Martens
Journal:  Circ Res       Date:  2012-07-27       Impact factor: 17.367

8.  Organ culture mimics the effects of hypoxia on membrane potential, K(+) channels and vessel tone in pulmonary artery.

Authors:  Boris Manoury; Sarah L Etheridge; Joy Reid; Alison M Gurney
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

9.  Cellular localization of mitochondria contributes to Kv channel-mediated regulation of cellular excitability in pulmonary but not mesenteric circulation.

Authors:  Amy L Firth; Dmitri V Gordienko; Kathryn H Yuill; Sergey V Smirnov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-19       Impact factor: 5.464

10.  Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.

Authors:  Jun Wan; Aya Yamamura; Adriana M Zimnicka; Guillaume Voiriot; Kimberly A Smith; Haiyang Tang; Ramon J Ayon; Moumita S R Choudhury; Eun A Ko; Jun Wang; Chen Wang; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-05-17       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.